UHCW
Coventry, Warwickshire, CV1 3LN, United Kingdom
NCT Number: NCT03064555
Chronic kidney disease (CKD) affects between 5-10% of the world's population, equating to ~740 million people worldwide. End stage renal disease (ESRD) is the result of a progressive loss of kidney function where the patient requires dialysis to replace the typical functions of the kidney. The quality of life of these individuals can be poor as a result of various complications associated with CKD (e.g. heart disease, diabetes, muscle wastage, decreased fitness). In an attempt to combat reduced physical fitness, many studies have applied long term exercise programmes. However, the body's response to exercise in people with CKD is not well understood and a set of guidelines that informs safe and effective exercise prescription is lacking.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Coventry, Warwickshire, CV1 3LN, United Kingdom
Chronic kidney disease (CKD) affects between 5-10% of the world's population, equating to ~740 million people worldwide. End stage renal disease (ESRD) is the result of a progressive loss of kidney function where the patient requires dialysis to replace the typical functions of the kidney. The quality of life (QOL) of these individuals is severely impaired as a result of various complications associated with CKD (e.g. heart disease, diabetes, muscle wastage, decreased fitness). In an attempt to combat this decrease in physical fitness, many studies have applied long term exercise interventions. However, the acute response to exercise in this population is not entirely understood and a comprehensive set of guidelines that informs safe and effective exercise prescription is lacking.
The use of exercise as a therapeutic intervention in ESRD has grown in popularity, and evidence provided by numerous long term studies indicates cardiopulmonary, metabolic and inflammatory system adaptations. Despite these positive findings, the specific mechanisms through which exercise benefits these patients have not yet been fully established. In addition, the extent to which 'normal' physiology is acutely altered by dialysis treatment, and the effect that aerobic exercise may have on this, is unknown.
In patients with ESRD, this study aims to characterise the acute physiological response to exercise under different conditions. In doing so, the study aims to inform the development of guidelines for safe and effective intra-dialytic exercise training.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Participants with end stage renal disease
Inclusion criteria
Exclusion criteria
Healthy participants
Inclusion criteria
Exclusion criteria
Time frame: 2 months
Measurement of O2/CO2 kinetics.
Time frame: 2 months
Measurement of regional wall motion abnormalities.
Time frame: 2 months
Measurement of ejection fraction.
Time frame: 2 months
Measurement of cardiac output.
Time frame: 2 months
Investigation of cardiac, inflammatory and hormonal response to exercise.
Time frame: 2 months
Measurement of cardiac output during exercise,
Coventry University
Other
Acronym: PRECISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03242343
Aneurysm, Arterio-venous Fistula
Birmingham, Alabama, United States
View Trial DetailsNCT04810598
Chronic Disease, Disease Attributes
Orlando, Florida, United States
View Trial DetailsNCT02426684
Chronic Disease, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT03161197
Chronic Disease, Chronic Kidney Diseases
View Trial Details